Literature DB >> 22554802

Association of hepatitis C virus infection with risk of ESRD: a population-based study.

Fu-Hsiung Su1, Chien-Tien Su, Shih-Ni Chang, Pei-Chun Chen, Fung-Chang Sung, Cheng-Chieh Lin, Chih-Ching Yeh.   

Abstract

BACKGROUND: The association between chronic hepatitis C virus (HCV) infection and end-stage renal disease (ESRD) has been widely debated. STUDY
DESIGN: National population-based cohort study. SETTING & PARTICIPANTS: Insurance claims data from the Taiwan National Health Insurance Research Database in 2000-2005. PREDICTOR: Chronic HCV infection as defined by the International Classification of Diseases, Ninth Revision, Clinical Modification. OUTCOMES: ESRD as defined by the International Classification of Diseases, Ninth Revision, Clinical Modification.
RESULTS: We identified 6,291 adults with chronic HCV infection. The control group included 31,455 sex- and age-matched individuals without evidence of chronic hepatitis. The incidence of ESRD was 2.14-fold higher in patients with chronic HCV infection (HR, 1.53; 95% CI, 1.17-2.01; P = 0.002) than in patients without HCV infection. Age stratification analysis showed that patients aged 50-59 years with chronic HCV infection (HR, 7.77; 95% CI, 4.23-14.3; P < 0.001) had the highest risk of developing ESRD relative to patients aged 20-49 years without chronic HCV infection (interaction P < 0.001). LIMITATIONS: Lack of clinical data.
CONCLUSIONS: Patients with chronic HCV infection are at greater risk of developing ESRD than individuals without chronic HCV infection. In addition, the risk of developing ESRD is highest in younger patients with HCV infection. Early renal screening programs should be initiated for this high-risk group of young individuals with chronic HCV infection.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22554802     DOI: 10.1053/j.ajkd.2012.04.003

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  20 in total

1.  Association of Hepatitis C Virus Infection with Proteinuria and Glomerular Filtration Rate.

Authors:  Nargiza Kurbanova; Rehan Qayyum
Journal:  Clin Transl Sci       Date:  2015-08-14       Impact factor: 4.689

2.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 3.  Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection.

Authors:  Arpan Mohanty; Sarah Salameh; Adeel A Butt
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

4.  Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.

Authors:  Miklos Z Molnar; Hazem M Alhourani; Barry M Wall; Jun L Lu; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

5.  Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease.

Authors:  Meghan E Sise; Donald F Chute; Yaa Oppong; Maya I Davis; Joshua D Long; Sakuni T Silva; Nifasha Rusibamayila; Deborah Jean-Francois; Syeda Raji; Sophia Zhao; Ravi Thadhani; Raymond T Chung
Journal:  Kidney Int       Date:  2019-05-15       Impact factor: 10.612

Review 6.  Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Fabrizio Fabrizi; Simona Verdesca; Piergiorgio Messa; Paul Martin
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

7.  Estimating the causal effect of treatment with direct-acting antivirals on kidney function among individuals with hepatitis C virus infection.

Authors:  Adrienne O'Donnell; Nathan Pham; Leandra Battisti; Rachel Epstein; David Nunes; Deirdre Sawinski; Sara Lodi
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.752

8.  Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.

Authors:  Shari S Rogal; Peng Yan; David Rimland; Vincent Lo Re; Hind Al-Rowais; Linda Fried; Adeel A Butt
Journal:  Dig Dis Sci       Date:  2015-11-02       Impact factor: 3.199

9.  Tubular cell damage may be the earliest sign of renal extrahepatic manifestation caused by Hepatitis C.

Authors:  Kati Kaartinen; Sauli Vuoti; Eero Honkanen; Eliisa Löyttyniemi; Ravinder Singh; Martti Färkkilä
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

10.  Association Between Chronic Osteomyelitis and Risk of End-Stage Renal Disease: A Nationwide Population-Based Cohort Study.

Authors:  Shih-Yi Lin; Cheng-Li Lin; Chun-Hung Tseng; Yen-Jung Chang; I-Kuan Wang; Hung-Chieh Yeh; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.